Quanterix Corp at Barclays Global Healthcare Conference Transcript
Good afternoon, everybody. Winding it down here. With me today is Masoud Toloue, CEO of Quanterix, and he's going to give a presentation on the company and the current trends.
Thanks for having us. Of course, excited to be here. So before we begin, I just want to point to the -- our safe harbor statement. We have, for any forward-looking statements or any GAAP to non-GAAP reconciliations, you can take a look at the statement we have here. You i can also find it on our website.
So we're at a very exciting time in the history of the company, and I would say in the tools and diagnostics market in general. So number before -- are there a great number of discoveries happening in the protein signature space and the conversion of those signatures into biomarkers. And that really goes to the mission at Quanterix. We have an ultra-sensitive detection method for converting protein signatures into biomarkers, which
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |